Stefan Laufer

Overview

Best Publications

• Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology

  Matthias Gehringer;Stefan A. Laufer

  738
  Citations

• Candidate drugs against SARS-CoV-2 and COVID-19.

  Dwight L. McKee;Ariane Sternberg;Ulrike Stange;Stefan Laufer

  578
  Citations

• Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation

  Oliver Borst;Britta Walker;Patrick Münzer;Antonella Russo

  491
  Citations

• Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts.

  M. Fronza;B. Heinzmann;M. Hamburger;S. Laufer

  456
  Citations

• Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord.

  Sarah Taves;Temugin Berta;Da-Lu Liu;Sophie Gan

  312
  Citations

• In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer

  Ramona Rudalska;Daniel Dauch;Thomas Longerich;Katherine McJunkin

  308
  Citations

• A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

  Daniel Dauch;Ramona Rudalska;Giacomo Cossa;Jean-Charles Nault

  286
  Citations

• The Cysteinome of Protein Kinases as a Target in Drug Development.

  Apirat Chaikuad;Apirat Chaikuad;Pierre Koch;Stefan A. Laufer;Stefan Knapp

  237
  Citations

• Tetrasubstituted imidazole inhibitors of cytokine release: probing substituents in the N-1 position.

  Stefan A. Laufer;Werner Zimmermann;Kathrin J. Ruff

  233
  Citations

• Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

  Fabio Celotti;Stefan Laufer

  226
  Citations

• Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI

  Raynauld Jp;Martel-Pelletier J;Bias P;Laufer S

  223
  Citations

• The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K

  Jean-Pierre Pelletier;Christelle Boileau;Julie Brunet;Martin Boily

  209
  Citations

• Biological studies on Brazilian plants used in wound healing

  C. Schmidt;M. Fronza;M. Goettert;F. Geller

  203
  Citations

• Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1

  Andreas Koeberle;Ulf Siemoneit;Ulrike Bühring;Hinnak Northoff

  203
  Citations

• PGE(2) in the regulation of programmed erythrocyte death.

  P A Lang;D S Kempe;S Myssina;V Tanneur

  194
  Citations

• New Approaches to the Treatment of Inflammatory Disorders Small Molecule inhibitors of p38 MAP Kinase

  Christian Peifer;Gerd Wagner;Stefan Laufer

  177
  Citations

• (6,7-Diaryldihydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase.

  Stefan A. Laufer;Jan Augustin;Gerd Dannhardt;Werner Kiefer

  175
  Citations

• Progress towards a public chemogenomic set for protein kinases and a call for contributions

  David H. Drewry;Carrow I. Wells;David M. Andrews;Richard Angell

  171
  Citations

• Proteasome Activation by Small Molecules.

  Yves Leestemaker;Annemieke de Jong;Katharina F. Witting;Renske Penning

  166
  Citations

• Studies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers.

  Christoph A. Klaas;Gerd Wagner;Stefan Laufer;Silvio Sosa

  162
  Citations

• COX-3: just another COX or the solitary elusive target of paracetamol?

  Jan M Schwab;Hermann J Schluesener;Stefan Laufer

  153
  Citations